about
P108
P1416
Efficacy Multicentre Trial of ImmunoTherapy Vaccination With Abagovomab to Treat Ovarian Cancer PatientsThe Safety and Antitumor Activity of the Combination of Oregovomab and Hiltonol in Recurrent Advanced Ovarian CancerARIEL4: A Study of Rucaparib Versus Chemotherapy BRCA Mutant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer PatientsCoronary Orbital Atherectomy System StudyFeasibility Study With the Sirolimus-Eluting BX Velocity Balloon-Expandable Stent in the Treatment of Diabetic Patients With Native Coronary Artery LesionsTAXUS PERSEUS WorkhorseA Study of the TAXUS Liberté Stent for the Treatment of de Novo Coronary Artery Lesions in Small VesselsTAXUS ATLAS: TAXUS Liberté™-SR Stent for the Treatment of de Novo Coronary Artery LesionsA Study of the TAXUS Liberté Stent for the Treatment of Long De Novo Coronary Artery LesionsDirect Stenting of TAXUS Liberté™-SR Stent for the Treatment of Patients With de Novo Coronary Artery LesionsCombination Chemotherapy in Treating Young Patients With Down Syndrome and Acute Myeloid Leukemia or Myelodysplastic SyndromesA Phase III Randomized Trial of Metformin vs Placebo in Early Stage Breast CancerA Dose-Defining Study of CXL-1020 in Patients With Systolic Heart FailureEvaluate the Safety and Efficacy of OAS in Treating Severely Calcified Coronary LesionsA Trial of Amrubicin and Carboplatin With Pegfilgrastim in Patients With Extensive-Stage Small Cell Lung CancerSorafenib Tosylate in Treating Younger Patients With Relapsed or Refractory Rhabdomyosarcoma, Wilms Tumor, Liver Cancer, or Thyroid CancerThe PLATINUM Clinical Trial to Assess the PROMUS Element Stent System for Treatment of Long De Novo Coronary Artery Lesions (PLATINUM LL)The Evaluation of Bococizumab (PF-04950615; RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk SubjectsA Study of Rucaparib as Switch Maintenance Following Platinum-Based Chemotherapy in Patients With Platinum-Sensitive, High-Grade Serous or Endometrioid Epithelial Ovarian, Primary Peritoneal or Fallopian Tube CancerNab-paclitaxel and Gemcitabine vs Gemcitabine Alone as Adjuvant Therapy for Patients With Resected Pancreatic Cancer (the "Apact" Study)Bortezomib and Combination Chemotherapy in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia or Lymphoblastic LymphomaCombination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Promyelocytic LeukemiaSafety and Effectiveness of TactiCath™ Contact Force, Sensor Enabled™ (TactiCath SE) Catheter for Ablation of Drug Refractory, Symptomatic, Persistent Atrial FibrillationA Mixed Methods Evaluation of a Resilience Intervention With Psychoeducational Sessions for Critical Care NursesResilience Intervention for Critical Care NursesSafety and Effectiveness Evaluation of the Multi-Electrode Radiofrequency Balloon Catheter for the Treatment of Symptomatic Paroxysmal Atrial FibrillationBPS-314d-MR-PAH-303 (BEAT OLE)SYNTAX Study: TAXUS Drug-Eluting Stent Versus Coronary Artery Bypass Surgery for the Treatment of Narrowed Arteries131-I-TM-601 Study in Adults With Recurrent High-Grade GliomaCombination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic LeukemiaTLK286 (Telcyta) in Combination With Carboplatin (Paraplatin) Versus Doxil in Platinum Refractory or Resistant Ovarian CancerDNA Variations in the Gene in Young Patients With Wilms' TumorPexelizumab in Patients Undergoing Coronary Artery Bypass Grafting With Cardiopulmonary Bypass (PRIMO-CABG II)Efficacy of Å6 in Ovarian Cancer Patients Following First-Line Chemotherapy and a Rising CA125 LevelsCirculating Tumor DNA Exposure in Peripheral BloodSafety and Efficacy of RRx-001 in the Attenuation of Oral Mucositis in Patients Receiving Chemoradiation for the Treatment of Oral CancersBortezomib, Daunorubicin, and Cytarabine in Treating Older Patients With Previously Untreated Acute Myeloid LeukemiaStudy Evaluating The Combination Of Neratinib And Capecitabine In Solid Tumors And Breast CancerAn Efficacy and Safety Study of MORAb-003 in Platinum-Resistant or Refractory Relapsed Ovarian CancerA Study of ASA404 or Placebo in Combination With Docetaxel in Second-line Treatment for (Stage IIIb/IV) Non-small Cell Lung Cancer
P6153
Q58844406-B2E967E3-A2A2-43CD-87E9-F33362EB62E5Q58849985-FE2B101F-67DE-4739-A916-349B864D042BQ61862152-359BCFFE-F31F-4AA5-8F42-8CA48399D6EFQ61894229-FF475072-9C76-4186-8FC7-9852D3EBB879Q61918170-6BC1A7A5-8323-4861-9315-FE24FE7F8D78Q61918610-CF66C4B0-6103-4AE9-B2A0-62577E8212EAQ61933101-DCF2494C-ADC3-4876-BBF8-DAFD01270B00Q61933107-331A8E78-9DEC-40C0-9C82-64EFFC00E31FQ61933152-E26CD241-263D-4734-A93A-038351E42F63Q61933160-42AB680C-EAA1-4778-ABE3-52FFE6DD9171Q61933567-AC679E68-EBFD-4CD1-B7CC-BC5C06D0B91AQ61936011-E827DBE7-D33E-44EC-B9AF-D3946C8524BAQ61936602-19FF7DB9-4CE7-4AD3-83BD-286D048F6E65Q61936986-A8EB55BD-625B-4B5E-8400-5344A75A7A70Q61938125-34DBAD2E-91FE-4913-823B-E805BD1CA8FBQ61957502-E5CEF5B2-1106-4800-8EC7-73F397D9CD64Q61957720-3F906831-6B6E-4008-B154-04328286C79DQ61974962-53B8A63D-46E2-4FBD-8D48-97E63AF0424EQ61975530-A07CA888-1918-4248-8431-21F99F18702AQ61975843-7DB297EC-20C9-4443-B0EC-43110BCD7E41Q61980425-FB858196-EC48-424D-936F-E9DC5173BF76Q61980943-77EB7349-6D98-44CE-B6A8-5E3871DB41F6Q62025412-B5873996-8ACA-4356-B051-5DF2D85C4440Q62025806-86A5D2F5-AB1D-4837-B1E3-C5BF4E21C48CQ62025820-9DAA97FE-CCC6-4612-AC47-A591403067E0Q62054770-3194DD27-9DD5-478D-A6E9-AC80E7F079A1Q62062649-33BAAA60-DCE5-480D-88C8-001907339545Q62104811-F2366477-4832-41F8-A164-976AAF389173Q62104874-978D9ACE-1E96-48CA-900F-AE80652E2D9FQ62106060-C633E17C-7EF3-4297-AB35-4E4487D95360Q62106128-933B26EC-DC27-4B70-B089-B75EB39125E2Q62110114-4098E79B-0649-44A7-B602-3172ABC82680Q62110268-FB894993-E2DE-4502-B1BC-45897309A58DQ62110843-561E145A-370E-4D21-B17E-288C5A067BCFQ62817480-34EF013A-6DE4-4ABD-B137-43F8B372A625Q62818195-A637FA39-59BA-4ECC-8ED8-821C067C1AE6Q63062565-B698CD82-0957-464B-B943-8C086CDEA0E8Q63062711-0F94BC2C-26C0-4E9B-B29D-653D9DF214DCQ63063041-98FE7811-1E5A-440F-A606-6E4AE04FE436Q63063081-9CE69661-71BE-4490-9D21-FA0BAB53065B
P6153
description
griya sakit
@jv
healthcare organization in Orlando, United States
@en
rumah sakik
@min
rumah sakit di Amerika Serikat
@id
rumoh sakét
@ace
مستشفى في أورلاندو، فلوريدا، الولايات المتحدة
@ar
name
Florida Hospital Cancer Institute
@en
type
label
Florida Hospital Cancer Institute
@en
altLabel
FHCI
@en
prefLabel
Florida Hospital Cancer Institute
@en
P131
P213
0000 0004 0415 6213
P2427
grid.414938.3
P3500
P571
1996-01-01T00:00:00Z
P625
Point (-81.372247 28.575341)